- May also receive a free box of Novo Nordisk needlesa
- Offer is valid for Tresiba® FlexTouch® U-100 and U-200 and the U-100 vial
Savings for your commercially insured and Medicare Part D patients
Commercially insured patients
Medicare Part D patients
- Nearly 50% of Part D patients prescribed Tresiba® receive Low-Income Subsidy or Extra Help benefits1
- Average Medicare co-pays for Tresiba® are comparable with other branded basal insulins1,d
aNeedles are sold separately and may require a prescription in some states.
bResults based on average monthly patient out-of-pocket cost for Tresiba® 12-month rolling period from IQVIA LAAD, October 2019. Excludes cash-paying patients.
cMaximum savings of $150 per 30-day supply. Eligibility and other restrictions apply.
dOther branded basal insulins include Basaglar®, Lantus®, Levemir®, and Toujeo®.